Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and Reperfusion

[1]  J. Lowe,et al.  Effects of the cannabinoid CB 1 receptor antagonist SR 141716 A on the behavior of pigeons and rats , 2005 .

[2]  A. Hiltunen,et al.  Enantiomeric cannabinoids: stereospecificity of psychotropic activity , 1988, Experientia.

[3]  P. Casellas,et al.  Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. , 1999, Molecular pharmacology.

[4]  P B Bradley,et al.  International Union of Pharmacology. XII. Classification of opioid receptors. , 1996, Pharmacological reviews.

[5]  H. Vidrio,et al.  Cardiovascular effects of (−)-11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl in rats , 1996 .

[6]  Z. Vogel,et al.  ()--Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase (*) , 1996, The Journal of Biological Chemistry.

[7]  S. Welch.  Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice. , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  M. Curtis,et al.  Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. , 1993, Cardiovascular research.

[9]  M. Janse,et al.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. , 1989, Physiological reviews.

[10]  B. Martin,et al.  Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrine , 1987 .

[11]  R. Riemersma,et al.  Mechanisms of phase 1a and 1b early ventricular arrhythmias during acute myocardial ischemia in the dog. , 1984, The American journal of cardiology.